In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $48.95 in the prior trading day, Halozyme Therapeutics Inc (NASDAQ: HALO) closed at $52.02, up 6.27%. In other words, the price has increased by $6.27 from its previous closing price. On the day, 3.97 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HALO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.93. For the most recent quarter (mrq), Quick Ratio is recorded 7.30 and its Current Ratio is at 8.39. In the meantime, Its Debt-to-Equity ratio is 3.13 whereas as Long-Term Debt/Eq ratio is at 3.13.
On May 13, 2025, Leerink Partners Downgraded its rating to Underperform which previously was Market Perform but kept the price unchanged to $47.
Wells Fargo Downgraded its Overweight to Equal Weight on October 07, 2024, whereas the target price for the stock was revised from $58 to $62.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 28 ’25 when Henderson Jeffrey William sold 4,497 shares for $60.37 per share. The transaction valued at 271,467 led to the insider holds 28,611 shares of the business.
Henderson Jeffrey William sold 503 shares of HALO for $32,217 on Apr 01 ’25. The Director now owns 33,108 shares after completing the transaction at $64.05 per share. On Mar 03 ’25, another insider, Henderson Jeffrey William, who serves as the Director of the company, sold 5,000 shares for $58.69 each. As a result, the insider received 293,458 and left with 33,611 shares of the company.
Valuation Measures:
As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.80, and their Forward P/E ratio for the next fiscal year is 7.26. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.91 while its Price-to-Book (P/B) ratio in mrq is 13.29.
Stock Price History:
Over the past 52 weeks, HALO has reached a high of $70.50, while it has fallen to a 52-week low of $42.01. The 50-Day Moving Average of the stock is -14.49%, while the 200-Day Moving Average is calculated to be -7.73%.
Shares Statistics:
A total of 123.17M shares are outstanding, with a floating share count of 121.86M. Insiders hold about 1.10% of the company’s shares, while institutions hold 100.34% stake in the company.
